The systemic hormonal preparations market in Italy, excluding sex hormones and insulins, shows a stable per capita sales value from 2024 to 2028, maintaining an average of 9.3 USD, following a slight decrease from 9.4 USD in 2024. In 2023, this market was slightly higher, indicating a downward trend as it enters the forecasted years. The nearly flat sales trend from 2024 through 2028 suggests a stabilized demand and possibly a saturated segment.
Future trends to watch:
- Potential impact of new hormonal therapies or biotechnologies on market dynamics.
- Regulatory changes affecting drug prices or reimbursement policies in Italy.
- Demographic shifts, such as an aging population, influencing the demand for hormonal treatments.
